F
S. Balalaie et al.
Letter
Synlett
(3) (a) Tietze, L. T. Domino Reactions, Concepts for Efficient Organic
Synthesis 2014. (b) Voskressensky, L. G.; Festa, A. A.; Varlamov,
A. V. Tetrahedron 2014, 70, 551.
Bioorg. Med. Chem. 2002, 10, 1979. (l) Chiou, W.; Liao, J.; Chen,
C. J. Nat. Prod. 1996, 59, 374. (m) Liang, J. L.; Cha, H. C.; Jahng, Y.
Molecules 2011, 16, 4861.
(4) (a) Dumas, A. M.; Fillion, E. Acc. Chem. Res. 2010, 43, 440. (b) El-
Gohary, N. S. Open Access Lib. J. 2014, 1, 1. (c) Lipson, V. V.;
Gorobets, N. Y. Mol. Diversity 2009, 13, 399. (d) Cui, S.; Walker,
S. D.; Woo, J. C. S.; Borths, C. J.; Mukherjee, H.; Chen, M. J.; Faul,
M. M. J. Am. Chem. Soc. 2010, 132, 436. (e) Zorzitto, A. K.; Fillion,
E. J. Am. Chem. Soc. 2009, 131, 14608. (f) Knöpfel, T. F.; Zarotti,
P.; Ichikawa, T.; Carreira, E. M. J. Am. Chem. Soc. 2005, 127, 9682.
(g) Yamashita, M.; Yamada, K.; Tomioka, K. Org. Lett. 2005, 7,
2369. (h) Knöpfel, T. F.; Carreira, E. M. J. Am. Chem. Soc. 2003,
125, 6054.
(12) General Procedure for the Synthesis of 3, 7, and 8
Typical Procedure for 3
To a solution of 3-formylchromone (1; 1 mmol, 174 mg) in
EtOH–H2O (4 mL; 1:1) was added Meldrum’s acid (2; 1 mmol,
144 mg), and the mixture was stirred for 3 h at ambient tem-
perature. The precipitate formed was isolated by filtration.
2,2-Dimethyl-5-[(4-oxo-4H-chromen-3-yl)methylene]-1,3-
dioxane-4,6-dione (3a)
Yellow powder. 1H NMR (300 MHz, DMSO-d6): δ = 1.78 (s, 6 H, 2
CH3), 7.56 (t, 1 H, J = 7.6 Hz, HAr), 7.73 (d, 1 H, J = 8.4 Hz, HAr),
7.87 (t, 1 H, J = 7.5 Hz, HAr), 8.10 (d, 1 H, J = 7.5 Hz, HAr), 8.26 (s,
1 H, =CH), 9.31 [s, 1 H, (CO2)2C=CH]. 13C NMR (75 MHz, DMSO-
d6): δ = 27.0, 104.9, 117.9, 118.0, 118.7, 123.1, 125.7, 126.7,
135.1, 145.5, 155.1, 159.8, 162.0, 162.2, 173.3.
(5) Plaskon, A. S.; Grygorenko, O. O.; Ryabukhlin, S. V. Tetrahedron
2012, 68, 2743.
(6) (a) Mohoney, S. J.; Lou, T.; Bondarenko, G.; Fillion, E. Org. Lett.
2012, 14, 3474. (b) Armstrong, E. L.; Grover, H. K.; Kerr, M. A.
J. Org. Chem. 2013, 78, 10534. (c) Wilsily, A.; Nguyen, Y.; Fillion,
E. J. Am. Chem. Soc. 2009, 131, 15606. (d) Wilsily, A.; Fillion, E.
Org. Lett. 2008, 13, 2801. (e) Armstrong, E. L.; Grover, H. K.; Kerr,
M. A. J. Org. Chem. 2013, 78, 10534.
General Procedure for 7
To a solution of isatoic anhydride (4; 1 mmol, 163 mg) in EtOH
(4 mL) was added the primary amine, aryl hydrazine, or aryl
hydrazide 5a–h (1 mmol), and the mixture was heated for 1 h at
70 °C. This mixture was used for the synthesis of 7a–n or 8a–d
without purification.
To a solution of product 6a–h (1 mmol) in EtOH (10 mL) was
added product 3 (1 mmol), and methanesulfonic acid (20 mol%,
20 mg), and the mixture was heated for 12 h at 70 °C. The reac-
tion reached completion as indicated by TLC (EtOAc–n-hexane,
1:3), and the precipitate was filtered. The precipitate was
washed with MeOH, and the resulting powder was pure
product 7a–n (yields 48–84%).
(7) (a) Dryager, C.; Möllers, N.; Kjäll, L. K.; Alao, J. P.; Dinér, P.;
Wallner, F. K.; Sunnerhagen, P.; Grøtli, M. J. Med. Chem. 2011, 54,
7427. (b) Mori, K.; Aurdan, G.; Monti, H. Synlett 1998, 259.
(c) Ghani, S. B. A.; Mugisha, P. J.; Wilcox, J. C.; Gado, E. A. M.;
Medu, E. O.; Lmb, A. J.; Brown, R. C. D. Synth. Commun. 2013, 43,
1549. (d) Fernández-Bachiller, M. I.; Pérez, C.; Monjas, L.;
Rademann, J.; Rodríguez-Franco, M. I. J. Med. Chem. 2012, 55,
1303. (e) Raju, B. C.; Rao, R. N.; Suman, P.; Yogeeswari, P.;
Sriram, D.; Shaik, T. B.; Kalivendi, S. V. Bioorg. Med. Chem. Lett.
2011, 21, 2855. (f) Valdameri, G.; Genoux-Bastide, E.; Peres, B.;
Gauthier, C.; Guitton, J.; Terreux, R.; Winnischofer, S. M. B.;
Rocha, M. E. M.; Boumendjel, A.; Di Pietro, A. J. Med. Chem. 2012,
55, 966. (g) Gaspar, A.; Matos, M. J.; Garrido, J.; Uriarte, E.;
Borges, F. Chem. Rev. 2014, 114, 4960. (h) Khadem, S.; Marles, R.
J. Molecules 2012, 17, 191.
2-(4-Oxo-4H-chromen-3-yl)-3-phenethyl-2,3-dihydro-
quinazolin-4(1H)-one (7c)
Yellow powder, 285 mg (72%), mp 228–230 °C. IR (KBr): ν =
3327, 1724, 1632 cm–1. 1H NMR (300 MHz, DMSO-d6): δ = 2.88
(dt, 2 H, J = 15.0, 6.6 Hz, CH2Ph), 3.10–3.14 (m, 1 H, CHPh), 4.05–
4.09 (m, 1 H, CHN), 5.97 (s, 1 H, CH), 6.68 (t, 1 H, J = 7.1 Hz, HAr),
6.75 (d, 1 H, J = 7.9 Hz, HAr), 6.92 (s, 1 H, NH), 7.16 (d, 1 H, J = 6.6
Hz, HAr), 7.19–7.23 (m, 5 H, HAr), 7.45 (t, 1 H, J = 7.2 Hz, HAr),
7.53 (d, 1 H, J = 6.6 Hz, HAr), 7.68–7.77 (m, 2 H, HAr), 7.97 (s, 1
H, =CH), 8.04 (d, 1 H, J = 7.6 Hz, HAr). 13C NMR (75 MHz, DMSO-
d6): δ = 33.8, 46.2, 64.3, 114.8, 114.9, 117.5, 118.4, 121.4, 123.1,
124.9, 125.7, 126.1, 127.4, 128.3, 128.7, 133.1, 134.5, 138.9,
146.0, 153.2, 155.7, 162.1, 176.1. ESI-HRMS: m/z calcd for
(8) (a) Teimouri, M. B.; Asnaashari, B.; Moayedi, M.; Naderi, S.
Synlett 2015, 26, 101. (b) Teimouri, M. B.; Akbari-Moghaddam,
P.; Golbaghi, G. ACS Comb. Sci. 2011, 13, 659. (c) Hao, W.-J.;
Jiang, B.; Tu, S.-J.; Wu, S.-S.; Han, Z.-G.; Cao, X.-D.; Zhang, X.-H.;
Yan, S.; Shi, F. J. Comb. Chem. 2009, 11, 310. (d) Sun, J.; Xia, E.-Y.;
Wu, Q.; Yan, C.-G. ACS Comb. Sci. 2011, 13, 421.
(9) Mehrparvar, S.; Balalaie, S.; Rabbanizadeh, M.; Ghabraie, E.;
Rominger, F. Mol. Diversity 2014, 18, 535.
C
25H21N2O3 [M + H]+: 397.1545; found: 397.1545.
(10) Mehrparvar, S.; Balalaie, S.; Rabbanizadeh, M.; Rominger, F.;
Ghabraie, E. Org. Biomol. Chem. 2014, 12, 5757.
Colorless crystal (polyhedron), dimensions 0.270 × 0.150 ×
0.130 mm3, crystal system monoclinic, space group C2/c, Z = 8,
a = 21.6199(9) Å, b = 15.8126(7) Å, c = 12.0816(5) Å, α = 90°, β =
95.9595(18)°, γ = 90°, V = 4108.0(3) Å3, ρ = 1.282 g cm–3, T =
200(2) K, θmax = 25.661°, radiation Mo Kα, λ = 0.71073 Å, 0.5° ω
scans with CCD area detector, covering the asymmetric unit in
reciprocal space with a mean redundancy of 4.29 and a com-
pleteness of 98.6% to a resolution of 0.83 Å, 17018 reflections
measured, 3847 unique [R(int) = 0.0280], 2992 observed [I >
2σ(I)], intensities were corrected for Lorentz and polarization
effects, an empirical absorption correction was applied using
SADABS based on the Laue symmetry of the reciprocal space, μ
= 0.09 mm–1, Tmin = 0.89, Tmax = 0.96, structure refined against F2
with a full-matrix least-squares algorithm using the SHELXL
(Version 2014-3) software, 275 parameters refined, hydrogen
atoms were treated using appropriate riding models, except H6
(11) (a) Mhaske, S. B.; Argade, N. P. Tetrahedron 2006, 62, 9787.
(b) Zhou, J.; Fang, J. J. Org. Chem. 2011, 76, 7730. (c) Granger, B.
A.; Kaneda, K.; Martin, S. F. Org. Lett. 2011, 13, 4542. (d) Sigel, E.
Med. Chem. Rev. 2005, 2, 251. (e) Hester, J. B. Jr. US 3,987,052,
1969. (f) Keller, O.; Steiger, N.; Sternbach, L. H. US 3,442,946,
1969. (g) Sharpless, K. B.; Manetsch, R. Expert Opin. Drug Discov-
ery 2006, 1, 525. (h) Mohapatra, D. K.; Maity, P. K.; Shabab, M.;
Khan, M. I. Bioorg. Med. Chem. Lett. 2009, 19, 5241. (i) Michael, J.
P. Nat. Prod. Rep. 2003, 20, 476. (j) Bandekar, P. P.; Roopnarine,
K. A.; Parekh, V. J.; Mitchell, T. R.; Novak, M. J.; Sinden, R. R.
J. Med. Chem. 2010, 53, 3558. (k) Bhattacharjee, A. K.; Skanchy,
D. J.; Jennings, B.; Hudson, T. H.; Brendle, J. J.; Werbovetz, K. A.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2015, 26, A–G